These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 12235256

  • 21. [Angioedema due to medication treatment].
    Timmenga NM, Spijkervet FK, Knol A.
    Ned Tijdschr Tandheelkd; 1996 Feb; 103(2):45-7. PubMed ID: 11921960
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin-converting enzyme inhibitor-associated angioedema.
    Byrd JB, Adam A, Brown NJ.
    Immunol Allergy Clin North Am; 2006 Nov; 26(4):725-37. PubMed ID: 17085287
    [Abstract] [Full Text] [Related]

  • 23. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 24. Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus.
    Mathey CM, Maj C, Eriksson N, Krebs K, Westmeier J, David FS, Koromina M, Scheer AB, Szabo N, Wedi B, Wieczorek D, Amann PM, Löffler H, Koch L, Schöffl C, Dickel H, Ganjuur N, Hornung T, Buhl T, Greve J, Wurpts G, Aygören-Pürsün E, Steffens M, Herms S, Heilmann-Heimbach S, Hoffmann P, Schmidt B, Mavarani L, Andresen T, Sørensen SB, Andersen V, Vogel U, Landén M, Bulik CM, Estonian Biobank Research Team, DBDS Genomic Consortium, Bygum A, Magnusson PKE, von Buchwald C, Hallberg P, Rye Ostrowski S, Sørensen E, Pedersen OB, Ullum H, Erikstrup C, Bundgaard H, Milani L, Rasmussen ER, Wadelius M, Ghouse J, Sachs B, Nöthen MM, Forstner AJ.
    J Allergy Clin Immunol; 2024 Apr; 153(4):1073-1082. PubMed ID: 38300190
    [Abstract] [Full Text] [Related]

  • 25. ACE inhibitor-induced angioedema.
    Baram M, Kommuri A, Sellers SA, Cohn JR.
    J Allergy Clin Immunol Pract; 2013 Apr; 1(5):442-5. PubMed ID: 24565614
    [Abstract] [Full Text] [Related]

  • 26. Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation.
    Molinaro G, Adam A, Lepage Y, Hammerschmidt D, Koenigbauer U, Eastlund T.
    Transfusion; 2002 Nov; 42(11):1458-65. PubMed ID: 12421219
    [Abstract] [Full Text] [Related]

  • 27. [Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema].
    Nosbaum A, Bouillet L, Floccard B, Javaud N, Launay D, Boccon-Gibod I, Fain O, Groupe d’experts du CREAK, French National Center for Angioedema.
    Rev Med Interne; 2013 Apr; 34(4):209-13. PubMed ID: 23380506
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L, Fortin JP, Adam A, Stewart JM, Marceau F.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece.
    Symvoulakis EK, Kyrmizakis DE, Drivas EI, Bizakis J, Velegrakis GA, Lionis C.
    Eur J Gen Pract; 2007 Apr; 13(4):239-41. PubMed ID: 18324507
    [Abstract] [Full Text] [Related]

  • 31. [ACE-inhibitor induced angioedema].
    Bas M, Hoffmann TK, Kojda G, Bier H.
    Laryngorhinootologie; 2007 Nov; 86(11):804-8, quiz 809-13. PubMed ID: 17966084
    [Abstract] [Full Text] [Related]

  • 32. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].
    Roskiewicz F, Andriamanana I, Gras-Champel V, Andrejak M, Massy ZA.
    Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310
    [Abstract] [Full Text] [Related]

  • 33. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
    Nielsen EW, Gramstad S.
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
    [Abstract] [Full Text] [Related]

  • 34. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.
    Sigler C, Annis K, Cooper K, Haber H, Van deCarr S.
    Arch Dermatol; 1997 Aug; 133(8):972-5. PubMed ID: 9267242
    [Abstract] [Full Text] [Related]

  • 35. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
    Jeon J, Lee YJ, Lee SY.
    J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
    [Abstract] [Full Text] [Related]

  • 36. Bradykinin and the pathophysiology of angioedema.
    Cugno M, Nussberger J, Cicardi M, Agostoni A.
    Int Immunopharmacol; 2003 Mar; 3(3):311-7. PubMed ID: 12639808
    [Abstract] [Full Text] [Related]

  • 37. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F.
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [Abstract] [Full Text] [Related]

  • 38. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
    Schmidt PW, Hirschl MM, Trautinger F.
    J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347
    [No Abstract] [Full Text] [Related]

  • 39. Fate of bradykinin on the rat liver when administered by the venous or arterial route.
    Gioli-Pereira L, Nascimento EA, Santos EL, Bracht A, Juliano MA, Pesquero JB, Borges DR, Kouyoumdjian M.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493
    [Abstract] [Full Text] [Related]

  • 40. Angioedema induced by angiotensin-converting enzyme inhibitors.
    Campo P, Fernandez TD, Canto G, Mayorga C.
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):337-44. PubMed ID: 23743513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.